48 related articles for article (PubMed ID: 19177585)
1. The optimal ribavirin dose for patients infected with hepatitis C virus genotype 3: should we utilize more?
Aghemo A; Rumi MG; Prati GM; Colombo M
Hepatology; 2009 Feb; 49(2):702-3; author reply 703-4. PubMed ID: 19177585
[No Abstract] [Full Text] [Related]
2. Rapid virological response in hepatitis C virus genotype 1 and early ribavirin exposure.
Dai CY; Chuang WL; Huang JF; Hsieh MY; Yu ML
Hepatology; 2008 Aug; 48(2):692-3; author reply 693-4. PubMed ID: 18666250
[No Abstract] [Full Text] [Related]
3. Usefulness of monitoring ribavirin plasma concentrations to improve treatment response in patients with chronic hepatitis C.
Morello J; Rodríguez-Novoa S; Jiménez-Nácher I; Soriano V
J Antimicrob Chemother; 2008 Dec; 62(6):1174-80. PubMed ID: 18931138
[TBL] [Abstract][Full Text] [Related]
4. Ribavirin in chronic hepatitis C: past and future.
Loustaud-Ratti V; Rousseau A; Marquet P; Denis F; Alain S
Expert Rev Anti Infect Ther; 2009 Apr; 7(3):249-53. PubMed ID: 19344238
[No Abstract] [Full Text] [Related]
5. How to use virological tools for optimal management of chronic hepatitis C.
Chevaliez S; Pawlotsky JM
Liver Int; 2009 Jan; 29 Suppl 1():9-14. PubMed ID: 19207960
[TBL] [Abstract][Full Text] [Related]
6. Treatment of patients infected with chronic hepatitis C genotype 2 and 3: more data, more questions?
Graziadei IW; Vogel W
Hepatology; 2009 Feb; 49(2):345-7. PubMed ID: 19177579
[No Abstract] [Full Text] [Related]
7. Development of thyroid diseases in the treatment of chronic hepatitis C with alpha-interferon may be a good prognosticator in achieving a sustained virological response: a meta-analysis.
Tran HA; Malcolm Reeves GE; Gibson R; Attia JR
J Gastroenterol Hepatol; 2009 Jul; 24(7):1163-8. PubMed ID: 19682190
[TBL] [Abstract][Full Text] [Related]
8. Serine protease inhibitors as anti-hepatitis C virus agents.
Reiser M; Timm J
Expert Rev Anti Infect Ther; 2009 Jun; 7(5):537-47. PubMed ID: 19485794
[TBL] [Abstract][Full Text] [Related]
9. Virological relapse in chronic hepatitis C.
Poordad FF; Flamm SL
Antivir Ther; 2009; 14(3):303-13. PubMed ID: 19474464
[TBL] [Abstract][Full Text] [Related]
10. Towards predicting the therapeutic response in patients with hepatitis C.
Féray C
Aliment Pharmacol Ther; 2010 Jan; 31(2):339-40; author reply 340-1. PubMed ID: 20078498
[No Abstract] [Full Text] [Related]
11. Association of lipid profiles with hepatitis C viral load in chronic hepatitis C patients with genotype 1 or 2 infection.
Hsu CS; Liu CH; Liu CJ; Wang CC; Chen CL; Lai MY; Chen PJ; Chen DS; Kao JH
Am J Gastroenterol; 2009 Mar; 104(3):598-604. PubMed ID: 19262519
[TBL] [Abstract][Full Text] [Related]
12. [Ribavirin].
Taéron C
Rev Infirm; 2009; (152):47-9. PubMed ID: 19702029
[No Abstract] [Full Text] [Related]
13. Erythropoietin for ribavirin-induced anemia in hepatitis C: more answers but many more questions.
Dev A; Patel K; Muir A; McHutchison JG
Am J Gastroenterol; 2003 Nov; 98(11):2344-7. PubMed ID: 14638332
[No Abstract] [Full Text] [Related]
14. Assessing ribavirin exposure during pregnancy: the Ribavirin Pregnancy Registry.
Roberts SS
Gastroenterol Nurs; 2008; 31(6):413-7. PubMed ID: 19077835
[TBL] [Abstract][Full Text] [Related]
15. [Difficulties for the detection of multiple genotypes of hepatitis C virus].
Parodi C; Baré P
Medicina (B Aires); 2007; 67(1):96-8. PubMed ID: 17408030
[No Abstract] [Full Text] [Related]
16. [Hepatitis C virus genotypes distribution and viral load level among HIV-coinfected patients].
Bolcic F; Laufer N; Quarleri J
Acta Gastroenterol Latinoam; 2008 Dec; 38(4):307. PubMed ID: 19160588
[No Abstract] [Full Text] [Related]
17. [Hepatitis C virus infection and human genetics].
Benfield T; Clausen LN
Ugeskr Laeger; 2011 Mar; 173(10):730. PubMed ID: 21375989
[No Abstract] [Full Text] [Related]
18. Chronic hepatitis C.
Shiffman ML
Semin Liver Dis; 2004; 24 Suppl 2():1-2. PubMed ID: 15346239
[No Abstract] [Full Text] [Related]
19. Nonalcoholic steatohepatitis in chronic hepatitis C: A new classification?
Chávez-Tapia NC; Tellez-Avila FI;
Hepatology; 2008 Feb; 47(2):759; author reply 759-60. PubMed ID: 18069695
[No Abstract] [Full Text] [Related]
20. [Hepatitis C. How can we eradicate the definitive virus?].
Melman ML
Rev Gastroenterol Mex; 2004 Nov; 69 Suppl 3():138-9. PubMed ID: 16881218
[No Abstract] [Full Text] [Related]
[Next] [New Search]
